Acquiring Company
DCN Dx
Acquired Company
BioSouthTech
FloridaData And AnalyticsHealth CareScience And EngineeringHealth CareDescription
DCN Dx has acquired BioSouthTech, Inc., a Miami-area human biospecimen provider with a Latin American collection network. The deal expands DCN Dx's sample bank and access to diverse patient populations for drug and diagnostic research. DCN Dx customers can now request banked tissue or stand-up prospective collections across oncology, neurology, and infectious disease.
Who to call at DCN Dx, and when
When DCN Dx changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day DCN Dx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at DCN Dx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at DCN Dx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment DCN Dx makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BioSouthTech?
BioSouthTech was acquired by DCN Dx. The deal was reported on October 29, 2026. CN Dx is a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests. DCN Dx is privately held and operates in Data And Analytics.
When did DCN Dx acquire BioSouthTech?
DCN Dx's acquisition of BioSouthTech was reported on October 29, 2026. DCN Dx has acquired BioSouthTech, Inc., a Miami-area human biospecimen provider with a Latin American collection network. The deal expands DCN Dx's sample bank and access to diverse patient populations for drug and diagnostic research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BioSouthTech do?
BioSouthTech is a human biospecimen provider with a collection network across Latin America, including South America. It also offers access to specimens from the Caribbean. Its banked specimens broaden patient representation for research. It is privately held, operating in Health Care, and is based in Florida.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.